 |  |  |
|---|---|---|
 |  |  |
 |  |
With 27 years experiences in conducting HIV research including HIV vaccine, HIV biomedical prevention
and treatment in various populations to develop academic knowledge on HIV / AIDS,
we have worked in collaboration with leading international research networks and other domestic agencies.
Our diverse research programs are up-to-date with present situation and necessity of knowledge both nationally and globally
We are ready to expand our field of expertise to other challenging infectious diseases and substance use
News
Research Studies Currently Underway
To learn more click Study title (to visit webpage) or Study snapshot (in Thai)
What Do People Who Practice Anal Sex Desire for Preventing HIV?
Rectal douche
Rectal suppository
Rectal insert
What the body of HIV-infected adolescents do to these new drugs? Are they safe for this population?
Doravirine (DOR) and
Doravirine, lamivudine, and
tenofovir disoproxil fumarate
fixed dose combination (DOR/3TC/TDF)
JNJ-53718678 is an investigational respiratory syncytial virus (RSV) specific fusion inhibitor.
This study wants to evaluate the antiviral activity, clinical outcomes, safety of this new drug in children age ≥28 Days to ≤3 Years with respiratory syncytial virus (RSV) disease
Contact Us
Research Institute for Health Sciences, Chiang Mai University
110 Intavaroros Road, Sriphum, Muang
Chiang Mai 50200 THAILAND
Tel. 66 5393 6148
HIV RUN 2019
December 01, 2019
World AIDS Day event
Communities Make The Difference
December 03, 2019
Gang SAA go to
the south
January 08, 2020